AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Analysis of Dara KRD treatment for newly diagnosed myeloma patients and the role of mass spectrometry
This chapter analyzes the use of Dara KRD as a treatment for newly diagnosed myeloma patients, focusing on different administration schedules and patient outcomes. It highlights the achievement of the primary endpoint, progression-free survival rates, and the impact of high-risk abnormalities on patient outcomes.